APA (7th ed.) Citation

AK, H., AB, R., M, T., D, M., KL, C., K, P., . . . SJ, D. (2024). A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma. Cancer cell, 42(11), 1970. https://doi.org/10.1016/j.ccell.2024.10.003

Chicago Style (17th ed.) Citation

AK, Hamilton, et al. "A Proteogenomic Surfaceome Study Identifies DLK1 as an Immunotherapeutic Target in Neuroblastoma." Cancer Cell 42, no. 11 (2024): 1970. https://doi.org/10.1016/j.ccell.2024.10.003.

MLA (9th ed.) Citation

AK, Hamilton, et al. "A Proteogenomic Surfaceome Study Identifies DLK1 as an Immunotherapeutic Target in Neuroblastoma." Cancer Cell, vol. 42, no. 11, 2024, p. 1970, https://doi.org/10.1016/j.ccell.2024.10.003.